Glycobiology is gaining popularity as a result of its growing uses in pharmaceutical medication development and industrial biotechnology.
Glycobiology is one of two primary fields of study that look at the metabolic characteristics of different carbs and starches. In its broadest sense, glycobiology is the study of the molecular biology, structure, and physiology of diverse saccharides found in nature. It is a rapidly growing field that spans a wide range of scientific disciplines. Glycobiology has made major contributions to our understanding of a variety of ailments and diseases with modern therapeutic options. Among these are conditions with symptoms comparable to diabetes, such as Type I and Type II diabetes, as well as metabolic disorders such as fatty liver disease (fatty liver).
The global glycobiology market is estimated to be valued at US$ 1,165.3 million in 2020 and is expected to exhibit a CAGR of 12.8 % during the forecast period (2020–2027).
The increasing number of product launches such as mass spectrometry devices, high profile liquid chromatography (HPLC) devices, and others is expected to drive the global glycobiology market growth over the forecast period. For instance, in May 2020, Thermo Fisher Scientific Inc. announced the launch of Thermo Scientific Orbitrap Exploris 240 and Thermo Scientific Orbitrap Exploris 120 mass spectrometers. The spectrometers are used for identification of proteins and peptides.
Several non-profit and governmental organisations are providing research funding to universities and research laboratories in order to boost glycobiology research, which is likely to drive segment growth in the global glycobiology market.
For example, the National Research and Development and Innovation Office of Hungary and the European Regional Development Fund supported a study at the University of Debrecen in February 2020. The study comprises the synthesis of a new series of 2-c-(-d-glucopyranosyl)-pyrimidines and their assessment as glycoenzyme inhibitors.
Major players operating in the global glycobiology market are Merck & Co., Inc., Bio-Techne Corporation, Bruker Corporation, Thermo Fisher Scientific Inc., Shimadzu Corporation, Plexera LLC, New England Biolabs, Agilent Technologies, Inc.
